Inhaled budesonide for COVID-19 in people at high risk of complications in the community in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial. (2021)
Attributed to:
Platform Randomised trial of INterventions against COVID-19 In older peoPLE (PRINCIPLE)
funded by
COVID
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/s0140-6736(21)01744-x
PubMed Identifier: 34388395
Publication URI: http://europepmc.org/abstract/MED/34388395
Type: Journal Article/Review
Volume: 398
Parent Publication: Lancet (London, England)
Issue: 10303
ISSN: 0140-6736